nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—GBA2—Sphingolipid metabolism—ACER3—melanoma	0.0494	0.125	CbGpPWpGaD
Miglustat—UGCG—Sphingolipid metabolism—ACER3—melanoma	0.0452	0.115	CbGpPWpGaD
Miglustat—GBA2—eye—melanoma	0.0294	0.137	CbGeAlD
Miglustat—GBA2—retina—melanoma	0.0291	0.135	CbGeAlD
Miglustat—UGCG—retina—melanoma	0.0287	0.133	CbGeAlD
Miglustat—UGCG—skin of body—melanoma	0.0252	0.117	CbGeAlD
Miglustat—GBA2—mammalian vulva—melanoma	0.0233	0.108	CbGeAlD
Miglustat—UGCG—mammalian vulva—melanoma	0.023	0.107	CbGeAlD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—GAB2—melanoma	0.0219	0.0556	CbGpPWpGaD
Miglustat—GBA2—head—melanoma	0.0167	0.0776	CbGeAlD
Miglustat—UGCG—head—melanoma	0.0164	0.0765	CbGeAlD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—E2F1—melanoma	0.0151	0.0383	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—TERT—melanoma	0.0138	0.0349	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—RAC1—melanoma	0.0137	0.0348	CbGpPWpGaD
Miglustat—GBA2—lymph node—melanoma	0.0117	0.0543	CbGeAlD
Miglustat—UGCG—lymph node—melanoma	0.0115	0.0535	CbGeAlD
Miglustat—Disorder sight—Temozolomide—melanoma	0.00941	0.0241	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.00935	0.0237	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—BCL2—melanoma	0.00927	0.0235	CbGpPWpGaD
Miglustat—Polyneuropathy—Docetaxel—melanoma	0.00914	0.0234	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.00855	0.0217	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—IL2—melanoma	0.00816	0.0207	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—NFKB1—melanoma	0.00764	0.0194	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—MYC—melanoma	0.00638	0.0162	CbGpPWpGaD
Miglustat—Pain in extremity—Vemurafenib—melanoma	0.00636	0.0163	CcSEcCtD
Miglustat—Coagulopathy—Dactinomycin—melanoma	0.00636	0.0163	CcSEcCtD
Miglustat—Influenza-like symptoms—Temozolomide—melanoma	0.00627	0.0161	CcSEcCtD
Miglustat—Coagulopathy—Temozolomide—melanoma	0.00575	0.0147	CcSEcCtD
Miglustat—Memory impairment—Temozolomide—melanoma	0.00571	0.0146	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.00566	0.0144	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—PIK3CA—melanoma	0.00542	0.0137	CbGpPWpGaD
Miglustat—Menstruation irregular—Docetaxel—melanoma	0.00538	0.0138	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.00518	0.0131	CbGpPWpGaD
Miglustat—Weight decreased—Vemurafenib—melanoma	0.00497	0.0127	CcSEcCtD
Miglustat—Neuropathy peripheral—Vemurafenib—melanoma	0.00481	0.0123	CcSEcCtD
Miglustat—Gait disturbance—Carmustine—melanoma	0.00475	0.0122	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.00473	0.012	CbGpPWpGaD
Miglustat—Gait disturbance—Temozolomide—melanoma	0.00459	0.0117	CcSEcCtD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—AKT1—melanoma	0.00442	0.0112	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.00442	0.0112	CbGpPWpGaD
Miglustat—Neuropathy—Carmustine—melanoma	0.00435	0.0111	CcSEcCtD
Miglustat—Influenza like illness—Temozolomide—melanoma	0.00435	0.0111	CcSEcCtD
Miglustat—Connective tissue disorder—Vemurafenib—melanoma	0.00432	0.0111	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.00432	0.011	CbGpPWpGaD
Miglustat—Neuropathy—Temozolomide—melanoma	0.00421	0.0108	CcSEcCtD
Miglustat—GBA2—Metabolism—ACER3—melanoma	0.00416	0.0106	CbGpPWpGaD
Miglustat—Eye disorder—Vemurafenib—melanoma	0.00411	0.0105	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.00404	0.0103	CbGpPWpGaD
Miglustat—Neuritis—Docetaxel—melanoma	0.00399	0.0102	CcSEcCtD
Miglustat—Chills—Vemurafenib—melanoma	0.00395	0.0101	CcSEcCtD
Miglustat—Malnutrition—Vemurafenib—melanoma	0.00383	0.00981	CcSEcCtD
Miglustat—UGCG—Metabolism—ACER3—melanoma	0.00381	0.00966	CbGpPWpGaD
Miglustat—GBA2—Metabolism—UGT2B10—melanoma	0.00381	0.00966	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00376	0.00954	CbGpPWpGaD
Miglustat—Back pain—Vemurafenib—melanoma	0.00371	0.00949	CcSEcCtD
Miglustat—Amnesia—Carmustine—melanoma	0.00358	0.00917	CcSEcCtD
Miglustat—GBA2—Metabolism—HS3ST5—melanoma	0.00354	0.00898	CbGpPWpGaD
Miglustat—UGCG—Metabolism—UGT2B10—melanoma	0.00348	0.00883	CbGpPWpGaD
Miglustat—Amnesia—Temozolomide—melanoma	0.00346	0.00886	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00344	0.00872	CbGpPWpGaD
Miglustat—UGCG—Metabolism—HS3ST5—melanoma	0.00324	0.00821	CbGpPWpGaD
Miglustat—Ataxia—Carmustine—melanoma	0.00316	0.0081	CcSEcCtD
Miglustat—Nervous system disorder—Vemurafenib—melanoma	0.00307	0.00785	CcSEcCtD
Miglustat—Ataxia—Temozolomide—melanoma	0.00306	0.00783	CcSEcCtD
Miglustat—Weight decreased—Bleomycin—melanoma	0.00301	0.00772	CcSEcCtD
Miglustat—Muscular weakness—Carmustine—melanoma	0.00297	0.0076	CcSEcCtD
Miglustat—Influenza like illness—Docetaxel—melanoma	0.00289	0.00741	CcSEcCtD
Miglustat—Muscular weakness—Temozolomide—melanoma	0.00287	0.00734	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.00285	0.00723	CbGpPWpGaD
Miglustat—Abdominal distension—Temozolomide—melanoma	0.00283	0.00724	CcSEcCtD
Miglustat—Neuropathy—Docetaxel—melanoma	0.0028	0.00716	CcSEcCtD
Miglustat—Decreased appetite—Vemurafenib—melanoma	0.00272	0.00696	CcSEcCtD
Miglustat—Gastrointestinal disorder—Vemurafenib—melanoma	0.0027	0.00691	CcSEcCtD
Miglustat—Fatigue—Vemurafenib—melanoma	0.0027	0.0069	CcSEcCtD
Miglustat—GBA2—Metabolism—PLCB4—melanoma	0.00268	0.0068	CbGpPWpGaD
Miglustat—Haemoglobin—Bleomycin—melanoma	0.00268	0.00686	CcSEcCtD
Miglustat—Constipation—Vemurafenib—melanoma	0.00267	0.00685	CcSEcCtD
Miglustat—Haemorrhage—Bleomycin—melanoma	0.00267	0.00683	CcSEcCtD
Miglustat—Hypoaesthesia—Bleomycin—melanoma	0.00265	0.00679	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—FASN—melanoma	0.00263	0.00668	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.00261	0.00661	CbGpPWpGaD
Miglustat—Depression—Carmustine—melanoma	0.00259	0.00662	CcSEcCtD
Miglustat—Weight decreased—Temozolomide—melanoma	0.00254	0.00651	CcSEcCtD
Miglustat—Neuropathy peripheral—Carmustine—melanoma	0.00254	0.00651	CcSEcCtD
Miglustat—GBA2—Metabolism—SLC6A11—melanoma	0.00252	0.0064	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PIP4K2A—melanoma	0.00252	0.0064	CbGpPWpGaD
Miglustat—Depression—Temozolomide—melanoma	0.0025	0.0064	CcSEcCtD
Miglustat—Neuropathy peripheral—Temozolomide—melanoma	0.00246	0.00629	CcSEcCtD
Miglustat—UGCG—Metabolism—PLCB4—melanoma	0.00245	0.00622	CbGpPWpGaD
Miglustat—GBA2—Metabolism—MTAP—melanoma	0.00245	0.00622	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—FASN—melanoma	0.00241	0.00611	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.0024	0.00608	CbGpPWpGaD
Miglustat—Chills—Bleomycin—melanoma	0.00239	0.00613	CcSEcCtD
Miglustat—Haemoglobin—Carmustine—melanoma	0.00234	0.00599	CcSEcCtD
Miglustat—Haemorrhage—Carmustine—melanoma	0.00233	0.00596	CcSEcCtD
Miglustat—Hypoaesthesia—Carmustine—melanoma	0.00232	0.00593	CcSEcCtD
Miglustat—UGCG—Metabolism—PIP4K2A—melanoma	0.00231	0.00585	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SLC6A11—melanoma	0.00231	0.00585	CbGpPWpGaD
Miglustat—Connective tissue disorder—Carmustine—melanoma	0.00229	0.00586	CcSEcCtD
Miglustat—Visual disturbance—Docetaxel—melanoma	0.00228	0.00584	CcSEcCtD
Miglustat—Haemoglobin—Temozolomide—melanoma	0.00226	0.00579	CcSEcCtD
Miglustat—Haemorrhage—Temozolomide—melanoma	0.00225	0.00576	CcSEcCtD
Miglustat—UGCG—Metabolism—MTAP—melanoma	0.00224	0.00569	CbGpPWpGaD
Miglustat—Asthenia—Vemurafenib—melanoma	0.00224	0.00574	CcSEcCtD
Miglustat—Visual impairment—Carmustine—melanoma	0.00224	0.00574	CcSEcCtD
Miglustat—Hypoaesthesia—Temozolomide—melanoma	0.00224	0.00573	CcSEcCtD
Miglustat—Chills—Dactinomycin—melanoma	0.00223	0.00571	CcSEcCtD
Miglustat—Connective tissue disorder—Temozolomide—melanoma	0.00221	0.00566	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.00219	0.00556	CbGpPWpGaD
Miglustat—GBA2—Metabolism—LUM—melanoma	0.00219	0.00555	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PHGDH—melanoma	0.00219	0.00555	CbGpPWpGaD
Miglustat—Eye disorder—Carmustine—melanoma	0.00218	0.00557	CcSEcCtD
Miglustat—Visual impairment—Temozolomide—melanoma	0.00217	0.00555	CcSEcCtD
Miglustat—Pain in extremity—Docetaxel—melanoma	0.00216	0.00554	CcSEcCtD
Miglustat—Ill-defined disorder—Bleomycin—melanoma	0.00215	0.00551	CcSEcCtD
Miglustat—GBA2—Metabolism—HPSE—melanoma	0.00215	0.00544	CbGpPWpGaD
Miglustat—Diarrhoea—Vemurafenib—melanoma	0.00214	0.00548	CcSEcCtD
Miglustat—Migraine—Docetaxel—melanoma	0.00213	0.00545	CcSEcCtD
Miglustat—GBA2—Metabolism—CUBN—melanoma	0.00211	0.00534	CbGpPWpGaD
Miglustat—Eye disorder—Temozolomide—melanoma	0.0021	0.00538	CcSEcCtD
Miglustat—Malaise—Bleomycin—melanoma	0.00209	0.00536	CcSEcCtD
Miglustat—Dizziness—Vemurafenib—melanoma	0.00207	0.00529	CcSEcCtD
Miglustat—Mental disorder—Carmustine—melanoma	0.00204	0.00522	CcSEcCtD
Miglustat—GBA2—Metabolism—SDHD—melanoma	0.00203	0.00516	CbGpPWpGaD
Miglustat—GBA2—Metabolism—BSG—melanoma	0.00203	0.00516	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CSPG4—melanoma	0.00203	0.00516	CbGpPWpGaD
Miglustat—Ataxia—Docetaxel—melanoma	0.00203	0.00521	CcSEcCtD
Miglustat—Malnutrition—Carmustine—melanoma	0.00203	0.00519	CcSEcCtD
Miglustat—Chills—Temozolomide—melanoma	0.00202	0.00517	CcSEcCtD
Miglustat—Ill-defined disorder—Dactinomycin—melanoma	0.00201	0.00514	CcSEcCtD
Miglustat—UGCG—Metabolism—PHGDH—melanoma	0.002	0.00507	CbGpPWpGaD
Miglustat—UGCG—Metabolism—LUM—melanoma	0.002	0.00507	CbGpPWpGaD
Miglustat—Vomiting—Vemurafenib—melanoma	0.00199	0.00509	CcSEcCtD
Miglustat—Abdominal pain upper—Docetaxel—melanoma	0.00197	0.00506	CcSEcCtD
Miglustat—Mental disorder—Temozolomide—melanoma	0.00197	0.00505	CcSEcCtD
Miglustat—GBA2—Metabolism—GPAM—melanoma	0.00197	0.00499	CbGpPWpGaD
Miglustat—UGCG—Metabolism—HPSE—melanoma	0.00196	0.00498	CbGpPWpGaD
Miglustat—Back pain—Carmustine—melanoma	0.00196	0.00502	CcSEcCtD
Miglustat—Headache—Vemurafenib—melanoma	0.00196	0.00501	CcSEcCtD
Miglustat—Malnutrition—Temozolomide—melanoma	0.00196	0.00501	CcSEcCtD
Miglustat—Discomfort—Bleomycin—melanoma	0.00195	0.005	CcSEcCtD
Miglustat—Malaise—Dactinomycin—melanoma	0.00195	0.005	CcSEcCtD
Miglustat—Cramp muscle—Docetaxel—melanoma	0.00195	0.00498	CcSEcCtD
Miglustat—UGCG—Metabolism—CUBN—melanoma	0.00193	0.00488	CbGpPWpGaD
Miglustat—Tremor—Carmustine—melanoma	0.0019	0.00486	CcSEcCtD
Miglustat—Back pain—Temozolomide—melanoma	0.00189	0.00485	CcSEcCtD
Miglustat—UGCG—Metabolism—SDHD—melanoma	0.00186	0.00472	CbGpPWpGaD
Miglustat—UGCG—Metabolism—BSG—melanoma	0.00186	0.00472	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CSPG4—melanoma	0.00186	0.00472	CbGpPWpGaD
Miglustat—Nausea—Vemurafenib—melanoma	0.00186	0.00475	CcSEcCtD
Miglustat—Thrombocytopenia—Bleomycin—melanoma	0.00185	0.00475	CcSEcCtD
Miglustat—Tremor—Temozolomide—melanoma	0.00183	0.0047	CcSEcCtD
Miglustat—Discomfort—Dactinomycin—melanoma	0.00182	0.00466	CcSEcCtD
Miglustat—Ill-defined disorder—Temozolomide—melanoma	0.00182	0.00465	CcSEcCtD
Miglustat—Anorexia—Bleomycin—melanoma	0.00181	0.00462	CcSEcCtD
Miglustat—UGCG—Metabolism—GPAM—melanoma	0.0018	0.00457	CbGpPWpGaD
Miglustat—Malaise—Temozolomide—melanoma	0.00177	0.00452	CcSEcCtD
Miglustat—Vertigo—Temozolomide—melanoma	0.00176	0.0045	CcSEcCtD
Miglustat—Convulsion—Carmustine—melanoma	0.00176	0.00449	CcSEcCtD
Miglustat—Thrombocytopenia—Dactinomycin—melanoma	0.00173	0.00443	CcSEcCtD
Miglustat—Paraesthesia—Bleomycin—melanoma	0.0017	0.00436	CcSEcCtD
Miglustat—Convulsion—Temozolomide—melanoma	0.0017	0.00434	CcSEcCtD
Miglustat—Weight decreased—Docetaxel—melanoma	0.00169	0.00433	CcSEcCtD
Miglustat—Anorexia—Dactinomycin—melanoma	0.00168	0.00431	CcSEcCtD
Miglustat—GBA2—Metabolism—PLA2G6—melanoma	0.00167	0.00425	CbGpPWpGaD
Miglustat—Discomfort—Temozolomide—melanoma	0.00165	0.00422	CcSEcCtD
Miglustat—Decreased appetite—Bleomycin—melanoma	0.00165	0.00422	CcSEcCtD
Miglustat—Neuropathy peripheral—Docetaxel—melanoma	0.00163	0.00418	CcSEcCtD
Miglustat—Dry mouth—Temozolomide—melanoma	0.00163	0.00417	CcSEcCtD
Miglustat—Pain—Bleomycin—melanoma	0.00162	0.00415	CcSEcCtD
Miglustat—Thrombocytopenia—Carmustine—melanoma	0.00162	0.00415	CcSEcCtD
Miglustat—Anorexia—Carmustine—melanoma	0.00158	0.00404	CcSEcCtD
Miglustat—Nervous system disorder—Temozolomide—melanoma	0.00157	0.00401	CcSEcCtD
Miglustat—Thrombocytopenia—Temozolomide—melanoma	0.00156	0.00401	CcSEcCtD
Miglustat—Feeling abnormal—Bleomycin—melanoma	0.00156	0.004	CcSEcCtD
Miglustat—Decreased appetite—Dactinomycin—melanoma	0.00154	0.00393	CcSEcCtD
Miglustat—UGCG—Metabolism—PLA2G6—melanoma	0.00153	0.00388	CbGpPWpGaD
Miglustat—Fatigue—Dactinomycin—melanoma	0.00152	0.0039	CcSEcCtD
Miglustat—Anorexia—Temozolomide—melanoma	0.00152	0.0039	CcSEcCtD
Miglustat—Pain—Dactinomycin—melanoma	0.00151	0.00387	CcSEcCtD
Miglustat—GBA2—Metabolism—VCAN—melanoma	0.0015	0.00381	CbGpPWpGaD
Miglustat—Haemoglobin—Docetaxel—melanoma	0.0015	0.00385	CcSEcCtD
Miglustat—Haemorrhage—Docetaxel—melanoma	0.0015	0.00383	CcSEcCtD
Miglustat—Insomnia—Carmustine—melanoma	0.0015	0.00383	CcSEcCtD
Miglustat—Hypoaesthesia—Docetaxel—melanoma	0.00149	0.00381	CcSEcCtD
Miglustat—Paraesthesia—Carmustine—melanoma	0.00148	0.0038	CcSEcCtD
Miglustat—Connective tissue disorder—Docetaxel—melanoma	0.00147	0.00376	CcSEcCtD
Miglustat—Feeling abnormal—Dactinomycin—melanoma	0.00146	0.00373	CcSEcCtD
Miglustat—Insomnia—Temozolomide—melanoma	0.00145	0.0037	CcSEcCtD
Miglustat—Gastrointestinal pain—Dactinomycin—melanoma	0.00144	0.0037	CcSEcCtD
Miglustat—Visual impairment—Docetaxel—melanoma	0.00144	0.00369	CcSEcCtD
Miglustat—Decreased appetite—Carmustine—melanoma	0.00144	0.00368	CcSEcCtD
Miglustat—Paraesthesia—Temozolomide—melanoma	0.00143	0.00367	CcSEcCtD
Miglustat—Gastrointestinal disorder—Carmustine—melanoma	0.00143	0.00365	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.00142	0.00361	CbGpPWpGaD
Miglustat—Pain—Carmustine—melanoma	0.00141	0.00362	CcSEcCtD
Miglustat—Constipation—Carmustine—melanoma	0.00141	0.00362	CcSEcCtD
Miglustat—Dyspepsia—Temozolomide—melanoma	0.00141	0.0036	CcSEcCtD
Miglustat—Eye disorder—Docetaxel—melanoma	0.0014	0.00358	CcSEcCtD
Miglustat—Abdominal pain—Dactinomycin—melanoma	0.0014	0.00358	CcSEcCtD
Miglustat—Decreased appetite—Temozolomide—melanoma	0.00139	0.00356	CcSEcCtD
Miglustat—Gastrointestinal disorder—Temozolomide—melanoma	0.00138	0.00353	CcSEcCtD
Miglustat—Fatigue—Temozolomide—melanoma	0.00138	0.00353	CcSEcCtD
Miglustat—UGCG—Metabolism—VCAN—melanoma	0.00138	0.00349	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.00137	0.00348	CbGpPWpGaD
Miglustat—Pain—Temozolomide—melanoma	0.00137	0.0035	CcSEcCtD
Miglustat—Constipation—Temozolomide—melanoma	0.00137	0.0035	CcSEcCtD
Miglustat—Feeling abnormal—Carmustine—melanoma	0.00136	0.00349	CcSEcCtD
Miglustat—Asthenia—Bleomycin—melanoma	0.00136	0.00348	CcSEcCtD
Miglustat—Gastrointestinal pain—Carmustine—melanoma	0.00135	0.00346	CcSEcCtD
Miglustat—Chills—Docetaxel—melanoma	0.00134	0.00344	CcSEcCtD
Miglustat—Feeling abnormal—Temozolomide—melanoma	0.00132	0.00337	CcSEcCtD
Miglustat—Mental disorder—Docetaxel—melanoma	0.00131	0.00335	CcSEcCtD
Miglustat—Abdominal pain—Carmustine—melanoma	0.00131	0.00335	CcSEcCtD
Miglustat—Gastrointestinal pain—Temozolomide—melanoma	0.00131	0.00335	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.0013	0.0033	CbGpPWpGaD
Miglustat—Malnutrition—Docetaxel—melanoma	0.0013	0.00333	CcSEcCtD
Miglustat—GBA2—Metabolism—CYP17A1—melanoma	0.00127	0.00322	CbGpPWpGaD
Miglustat—Asthenia—Dactinomycin—melanoma	0.00127	0.00325	CcSEcCtD
Miglustat—Abdominal pain—Temozolomide—melanoma	0.00126	0.00323	CcSEcCtD
Miglustat—Back pain—Docetaxel—melanoma	0.00126	0.00322	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.00126	0.00319	CbGpPWpGaD
Miglustat—Muscle spasms—Docetaxel—melanoma	0.00125	0.00321	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.00125	0.00317	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—ALB—melanoma	0.00124	0.00313	CbGpPWpGaD
Miglustat—Diarrhoea—Dactinomycin—melanoma	0.00121	0.00309	CcSEcCtD
Miglustat—Vomiting—Bleomycin—melanoma	0.0012	0.00308	CcSEcCtD
Miglustat—GBA2—Metabolism—GNA11—melanoma	0.0012	0.00304	CbGpPWpGaD
Miglustat—Asthenia—Carmustine—melanoma	0.00119	0.00304	CcSEcCtD
Miglustat—GBA2—Metabolism—FASN—melanoma	0.00117	0.00297	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CYP17A1—melanoma	0.00116	0.00294	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SLC5A5—melanoma	0.00115	0.00293	CbGpPWpGaD
Miglustat—Asthenia—Temozolomide—melanoma	0.00115	0.00294	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.00114	0.0029	CbGpPWpGaD
Miglustat—Diarrhoea—Carmustine—melanoma	0.00113	0.0029	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—ALB—melanoma	0.00113	0.00287	CbGpPWpGaD
Miglustat—Convulsion—Docetaxel—melanoma	0.00113	0.00289	CcSEcCtD
Miglustat—Nausea—Bleomycin—melanoma	0.00113	0.00288	CcSEcCtD
Miglustat—Vomiting—Dactinomycin—melanoma	0.00112	0.00288	CcSEcCtD
Miglustat—GBA2—Metabolism—GNAQ—melanoma	0.00111	0.00283	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CD44—melanoma	0.00111	0.00283	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GNA11—melanoma	0.0011	0.00278	CbGpPWpGaD
Miglustat—Dizziness—Carmustine—melanoma	0.00109	0.0028	CcSEcCtD
Miglustat—Diarrhoea—Temozolomide—melanoma	0.00109	0.0028	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.00109	0.00277	CbGpPWpGaD
Miglustat—Dry mouth—Docetaxel—melanoma	0.00108	0.00278	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.00108	0.00274	CbGpPWpGaD
Miglustat—UGCG—Metabolism—FASN—melanoma	0.00107	0.00272	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP1B1—melanoma	0.00107	0.00271	CbGpPWpGaD
Miglustat—Dizziness—Temozolomide—melanoma	0.00106	0.00271	CcSEcCtD
Miglustat—UGCG—Metabolism—SLC5A5—melanoma	0.00106	0.00268	CbGpPWpGaD
Miglustat—Vomiting—Carmustine—melanoma	0.00105	0.00269	CcSEcCtD
Miglustat—Nausea—Dactinomycin—melanoma	0.00105	0.00269	CcSEcCtD
Miglustat—Nervous system disorder—Docetaxel—melanoma	0.00104	0.00267	CcSEcCtD
Miglustat—Thrombocytopenia—Docetaxel—melanoma	0.00104	0.00266	CcSEcCtD
Miglustat—Headache—Carmustine—melanoma	0.00104	0.00265	CcSEcCtD
Miglustat—UGCG—Metabolism—GNAQ—melanoma	0.00102	0.00258	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CD44—melanoma	0.00102	0.00258	CbGpPWpGaD
Miglustat—Vomiting—Temozolomide—melanoma	0.00102	0.0026	CcSEcCtD
Miglustat—Anorexia—Docetaxel—melanoma	0.00101	0.00259	CcSEcCtD
Miglustat—Headache—Temozolomide—melanoma	0.001	0.00256	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000998	0.00253	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000989	0.00251	CbGpPWpGaD
Miglustat—Nausea—Carmustine—melanoma	0.000982	0.00251	CcSEcCtD
Miglustat—UGCG—Metabolism—CYP1B1—melanoma	0.000977	0.00248	CbGpPWpGaD
Miglustat—Insomnia—Docetaxel—melanoma	0.000961	0.00246	CcSEcCtD
Miglustat—Paraesthesia—Docetaxel—melanoma	0.000954	0.00244	CcSEcCtD
Miglustat—Nausea—Temozolomide—melanoma	0.000949	0.00243	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000943	0.00239	CbGpPWpGaD
Miglustat—Dyspepsia—Docetaxel—melanoma	0.000935	0.00239	CcSEcCtD
Miglustat—Decreased appetite—Docetaxel—melanoma	0.000924	0.00237	CcSEcCtD
Miglustat—Gastrointestinal disorder—Docetaxel—melanoma	0.000917	0.00235	CcSEcCtD
Miglustat—Fatigue—Docetaxel—melanoma	0.000916	0.00235	CcSEcCtD
Miglustat—Pain—Docetaxel—melanoma	0.000909	0.00233	CcSEcCtD
Miglustat—Constipation—Docetaxel—melanoma	0.000909	0.00233	CcSEcCtD
Miglustat—GBA2—Metabolism—ABCB1—melanoma	0.00088	0.00223	CbGpPWpGaD
Miglustat—Feeling abnormal—Docetaxel—melanoma	0.000876	0.00224	CcSEcCtD
Miglustat—Gastrointestinal pain—Docetaxel—melanoma	0.000869	0.00222	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000862	0.00219	CbGpPWpGaD
Miglustat—Abdominal pain—Docetaxel—melanoma	0.00084	0.00215	CcSEcCtD
Miglustat—GBA2—Metabolism—PRKCA—melanoma	0.00081	0.00205	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ABCB1—melanoma	0.000805	0.00204	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ERCC2—melanoma	0.000803	0.00204	CbGpPWpGaD
Miglustat—Asthenia—Docetaxel—melanoma	0.000762	0.00195	CcSEcCtD
Miglustat—UGCG—Metabolism—PRKCA—melanoma	0.00074	0.00188	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ERCC2—melanoma	0.000734	0.00186	CbGpPWpGaD
Miglustat—Diarrhoea—Docetaxel—melanoma	0.000727	0.00186	CcSEcCtD
Miglustat—Dizziness—Docetaxel—melanoma	0.000703	0.0018	CcSEcCtD
Miglustat—Vomiting—Docetaxel—melanoma	0.000676	0.00173	CcSEcCtD
Miglustat—Headache—Docetaxel—melanoma	0.000666	0.0017	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000665	0.00169	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PIK3CG—melanoma	0.000634	0.00161	CbGpPWpGaD
Miglustat—Nausea—Docetaxel—melanoma	0.000631	0.00162	CcSEcCtD
Miglustat—GBA2—Metabolism—PPARG—melanoma	0.000612	0.00155	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000608	0.00154	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PIK3CG—melanoma	0.00058	0.00147	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PPARG—melanoma	0.00056	0.00142	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PIK3CD—melanoma	0.000557	0.00141	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ALB—melanoma	0.00055	0.0014	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PIK3CD—melanoma	0.00051	0.00129	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ALB—melanoma	0.000503	0.00128	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PIK3CB—melanoma	0.000486	0.00123	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PTGS2—melanoma	0.000481	0.00122	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PIK3CB—melanoma	0.000444	0.00113	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PTGS2—melanoma	0.00044	0.00112	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PTEN—melanoma	0.00042	0.00106	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PTEN—melanoma	0.000384	0.000974	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PIK3CA—melanoma	0.000296	0.000751	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PIK3CA—melanoma	0.000271	0.000687	CbGpPWpGaD
Miglustat—GBA2—Metabolism—AKT1—melanoma	0.000242	0.000614	CbGpPWpGaD
Miglustat—UGCG—Metabolism—AKT1—melanoma	0.000221	0.000561	CbGpPWpGaD
